Targeting BCMA in Multiple Myeloma

被引：0
|
作者：
Carlyn Rose Tan
Urvi A. Shah
机构：
[1] Memorial Sloan Kettering Cancer Center,Myeloma Service Department of Medicine
来源：
Current Hematologic Malignancy Reports | 2021年 / 16卷
关键词：
Multiple myeloma; BCMA; CAR T cell therapy; Bispecific antibody constructs; Antibody-drug conjugates;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：367 / 383
页数：16
相关论文
共 50 条
  • [21] BCMA-targeted immunotherapy for multiple myeloma
    Yu, Bo
    Jiang, Tianbo
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [22] Antibody response to BCMA in patients with multiple myeloma
    Bellucci, R
    Wu, CJ
    Chiaretti, S
    Alyea, EP
    Munshi, NC
    Ritz, J
    IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION, 2004, : 355 - 359
  • [23] BCMA-targeted immunotherapy for multiple myeloma
    Bo Yu
    Tianbo Jiang
    Delong Liu
    Journal of Hematology & Oncology, 13
  • [24] An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma
    Lee, Lydia
    Draper, Benjamin
    Chaplin, Neil
    Philip, Brian
    Chin, Melody
    Galas-Filipowicz, Daria
    Onuoha, Shimobi
    Thomas, Simon
    Baldan, Vania
    Bughda, Reyisa
    Maciocia, Paul
    Kokalaki, Eva
    Neves, Margarida P.
    Patel, Dominic
    Rodriguez-Justo, Manuel
    Francis, James
    Yong, Kwee
    Pule, Martin
    BLOOD, 2018, 131 (07) : 746 - 758
  • [25] BCMA-targeting chimeric antigen receptor T-cell therapy for multiple myeloma
    Yang, Jinrong
    Zhou, Weilin
    Li, Dan
    Niu, Ting
    Wang, Wei
    CANCER LETTERS, 2023, 553
  • [26] BCMA CARs in multiple myeloma: room for more?
    Lee, Lydia Sarah Hui
    Yong, Kwee L.
    BLOOD, 2021, 137 (21) : 2859 - 2860
  • [27] B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
    Shah, Nina
    Chari, Ajai
    Scott, Emma
    Mezzi, Khalid
    Usmani, Saad Z.
    LEUKEMIA, 2020, 34 (04) : 985 - 1005
  • [28] BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma
    Fang, Jiamin
    Zhou, Fuling
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1069 - 1083
  • [29] Cilta-cel, a BCMA-targeting CAR-T therapy for patients with multiple myeloma
    Jagannath, Sundar
    Jackson, Carolyn C.
    Schecter, Jordan M.
    Lendvai, Nikoletta
    Sun, Huabin
    Akram, Muhammad
    Patel, Nitin
    Martin, Thomas G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (05) : 339 - 350
  • [30] Population pharmacokinetics of belantamab mafodotin, a BCMA-targeting agent in patients with relapsed/refractory multiple myeloma
    Rathi, Chetan
    Collins, Jon
    Struemper, Herbert
    Opalinska, Joanna
    Jewell, Roxanne C.
    Ferron-Brady, Geraldine
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (08): : 851 - 863
12345